PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wolfson Diabetes and Endocrinology Clinic, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.\', \'Department of Medical Genetics, Cambridge University, Cambridge, UK.\', \'Department of Endocrine Oncology, University Medical Centre Utrecht, ENETS Centre of Excellence, Utrecht, Netherlands.\', \'Division of Endocrinology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.\', \'Royal Free Hospital ENETs Centre of Excellence, London, UK.\', \'Centre for Endocrinology, Barts and the London School of Medicine, London, UK.\', \'Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.\', \'Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1530/EJE-20-0424EJE-20-0424
?:doi
?:hasPublicationType
?:journal
  • European journal of endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 32554825
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.892
?:rankingScore_hIndex
  • 126
is ?:relation_isRelatedTo_publication of
?:title
  • ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs).
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32554825>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32554825>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all